Alerts will be sent to your verified email
Verify Email
GUJTERC
|
Guj. Terce Lab
|
Mangalam Drugs&Org.
|
Sandu Pharmaceutical
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-11.74 % | -0.44 % | 3.72 % |
|
5yr average Equity Multiplier
|
3.3 | 2.43 | 1.33 |
|
5yr Average Asset Turnover Ratio
|
1.76 | 1.0 | 1.23 |
|
5yr Avg Net Profit Margin
|
-2.57 % | 0.0 | 2.27 % |
|
Price to Book
|
4.85 | 0.3 | 0.88 |
|
P/E
|
0.0 | 0.0 | 23.76 |
|
5yr Avg Cash Conversion Cycle
|
-20.6 Days | 17.41 Days | 48.49 Days |
|
Inventory Days
|
40.01 Days | 132.58 Days | 74.6 Days |
|
Days Receivable
|
39.02 Days | 38.43 Days | 26.14 Days |
|
Days Payable
|
100.7 Days | 126.53 Days | 72.73 Days |
|
5yr Average Interest Coverage Ratio
|
1.07 | 0.9 | 28.2 |
|
5yr Avg ROCE
|
3.46 % | 6.92 % | 5.33 % |
|
5yr Avg Operating Profit Margin
|
-0.49 % | 7.63 % | 3.77 % |
|
5 yr average Debt to Equity
|
0.63 | 0.59 | 0.0 |
|
5yr CAGR Net Profit
|
-17.21 % | 39.54 % | 0.39 % |
|
5yr Average Return on Assets
|
-3.57 % | -0.18 % | 2.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
37.03 % | 50.3 % | 42.91 % |
|
Share Pledged by Promoters
|
0.0 | 34.58 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.81 % | -0.12 % | -6.56 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Guj. Terce Lab
|
Mangalam Drugs&Org.
|
Sandu Pharmaceutical
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|